Table 2 from Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma
收藏Figshare2022-02-01 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Table_2_from_Repurposing_Vandetanib_plus_Everolimus_for_the_Treatment_of_i_ACVR1_i_-Mutant_Diffuse_Intrinsic_Pontine_Glioma/30834226
下载链接
链接失效反馈官方服务：
资源简介：
Summary of toxicities graded as per Common Terminology Criteria for Adverse Events version 4.03 related to vandetanib and/or mTOR inhibitors in three children with newly diagnosed ACVR1-mutant DIPG for a total of 9 cycles of vandetanib and 12 cycles of mTOR-inhibitor (11 cycles of everolimus and 1 cycle of sirolimus)
创建时间：
2022-02-01
